Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey C Pearson

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Infectious Diseases and Therapy|January 7, 2023
Contemporary Pharmacotherapies for Nontuberculosis Mycobacterial Infections: A Narrative ReviewTanner M Johnson, Thomas F Byrd, Wendi K Drummond, et al.
Open Forum Infectious Diseases|October 23, 2020
Omadacycline for the Treatment of <i>Mycobacterium abscessus</i> Disease: A Case SeriesJeffrey C Pearson, Brandon Dionne, Aaron Richterman, et al.
Open Forum Infectious Diseases|November 7, 2024
Implementation of a Pharmacist-Driven Vancomycin Area Under the Concentration-Time Curve Monitoring Program Using Bayesian Modeling in Outpatient Parenteral Antimicrobial TherapyEric Gillett, Muneerah M Aleissa, Jeffrey C Pearson, et al.
Open Forum Infectious Diseases|October 15, 2025
Evaluation of the Safety of Cefazolin Monotherapy in Outpatient Parenteral Antimicrobial Therapy at a Large Academic Medical CenterNicolas Poux, Eric Gillett, Catherine Franklin, et al.
Open Forum Infectious Diseases|April 23, 2024
Real-World Dalbavancin Use for Serious Gram-Positive Infections: Comparing Outcomes Between People Who Use and Do Not Use DrugsSarah Zambrano, Molly L Paras, Joji Suzuki, et al.
Antimicrobial Agents and Chemotherapy|November 7, 2025
Effectiveness of imipenem-relebactam for multidrug-resistant <i>Pseudomonas aeruginosa</i> in pneumonia and bloodstream infections in the United States (MIRAGE)Walaiporn Wangchinda, Janet Y Wu, Lilian M Abbo, et al.
Infectious Diseases and Therapy|March 1, 2024
Dalbavancin Sequential Therapy for Gram-Positive Bloodstream Infection: A Multicenter Observational StudyNicholas Rebold, Sara Alosaimy, Jeffrey C Pearson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 27, 2022
Evaluation of an Opt-Out Protocol for Antibiotic De-Escalation in Patients With Suspected Sepsis: A Multicenter, Randomized, Controlled TrialRebekah W Moehring, Michael E Yarrington, Bobby G Warren, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 22, 2025
2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: VilobelimabNandita Nadig, Adarsh Bhimraj, Kelly Cawcutt, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 9, 2025
2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: AbataceptNandita Nadig, Adarsh Bhimraj, Kelly Cawcutt, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Infectious Diseases and Therapy|January 7, 2023
Contemporary Pharmacotherapies for Nontuberculosis Mycobacterial Infections: A Narrative ReviewTanner M Johnson, Thomas F Byrd, Wendi K Drummond, et al.
Open Forum Infectious Diseases|October 23, 2020
Omadacycline for the Treatment of <i>Mycobacterium abscessus</i> Disease: A Case SeriesJeffrey C Pearson, Brandon Dionne, Aaron Richterman, et al.
Open Forum Infectious Diseases|November 7, 2024
Implementation of a Pharmacist-Driven Vancomycin Area Under the Concentration-Time Curve Monitoring Program Using Bayesian Modeling in Outpatient Parenteral Antimicrobial TherapyEric Gillett, Muneerah M Aleissa, Jeffrey C Pearson, et al.
Open Forum Infectious Diseases|October 15, 2025
Evaluation of the Safety of Cefazolin Monotherapy in Outpatient Parenteral Antimicrobial Therapy at a Large Academic Medical CenterNicolas Poux, Eric Gillett, Catherine Franklin, et al.
Open Forum Infectious Diseases|April 23, 2024
Real-World Dalbavancin Use for Serious Gram-Positive Infections: Comparing Outcomes Between People Who Use and Do Not Use DrugsSarah Zambrano, Molly L Paras, Joji Suzuki, et al.
Antimicrobial Agents and Chemotherapy|November 7, 2025
Effectiveness of imipenem-relebactam for multidrug-resistant <i>Pseudomonas aeruginosa</i> in pneumonia and bloodstream infections in the United States (MIRAGE)Walaiporn Wangchinda, Janet Y Wu, Lilian M Abbo, et al.
Infectious Diseases and Therapy|March 1, 2024
Dalbavancin Sequential Therapy for Gram-Positive Bloodstream Infection: A Multicenter Observational StudyNicholas Rebold, Sara Alosaimy, Jeffrey C Pearson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 27, 2022
Evaluation of an Opt-Out Protocol for Antibiotic De-Escalation in Patients With Suspected Sepsis: A Multicenter, Randomized, Controlled TrialRebekah W Moehring, Michael E Yarrington, Bobby G Warren, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 22, 2025
2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: VilobelimabNandita Nadig, Adarsh Bhimraj, Kelly Cawcutt, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 9, 2025
2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: AbataceptNandita Nadig, Adarsh Bhimraj, Kelly Cawcutt, et al.
Pageof 3